Search Videos and More

Showing 1 - 12 of 802 results

Previous| 1 | 2 | 3 ...67 |Next


ESMO26: Toni Choueiri, MD, on KEYNOTE-564 Video

ESMO26: Toni Choueiri, MD, on KEYNOTE-564

Final analysis of the pivotal KEYNOTE-564 trial in kidney cancer presented by Toni Choueiri, MD. After 7 years of follow-up, adjuvant pembrolizumab continued to extend disease-free survival and overall survival in high-risk clear-cell renal cell carcinoma.
ESMO26: Antonio Giordano, MD, PhD, on FOURLIGHT Video

ESMO26: Antonio Giordano, MD, PhD, on FOURLIGHT

Antonio Gioradano, MD, presents efficacy and safety of atirmociclib + fulvestrant in HR+/HER2- advanced breast cancer after progressing on prior CDK4/6 inhibitor - data from phase 2 FOURLIGHT-1 study.
ESMO26: Toni Choueiri, MD on LITESPARK-012 Video

ESMO26: Toni Choueiri, MD on LITESPARK-012

Surprising results in first triplet combination study in advanced kidney cancer presented by Toni Choueiri, MD, at #ESMO26. Dr. Choueiri says even though the combination did not improve efficacy, the findings are important for informing future studies.
ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer Video

ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer

Vincent (Wenxin) Xu, MD , shows among patients with advanced kidney cancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors.
ESMO26: Paolo Tarantino, MD on ADC Resistance in Breast Cancer Video

ESMO26: Paolo Tarantino, MD on ADC Resistance in Breast Cancer

Paolo Tarantino, MD, of Dana-Farber Cancer Institute, shows that antibody-drug conjugate (ADC) resistance appears to be driven by complex molecular adaptations beyond target modulation.
Turning Promise Into Progress News

Turning Promise Into Progress

How new cancer treatments reach patients and help shape the next cycle of discovery
Dana-Farber Research News 11.01.2026 News

Dana-Farber Research News 11.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from October 1 - 15.
Dana-Farber Science Uncovers Differences Between Early-Onset and Average-Age-Onset Colorectal Cancer News

Dana-Farber Science Uncovers Differences Between Early-Onset and Average-Age-Onset Colorectal Cancer

Colorectal cancer is on the rise in younger adults and appears to be different from colorectal cancer in older adults. The disease is often more aggressive in young people, and less responsive to treatment.  
Treatment Guideline: First-Line Treatment of HER2-Positive Metastatic Breast Cancer Document

Treatment Guideline: First-Line Treatment of HER2-Positive Metastatic Breast Cancer

The Breast Oncology Center held meetings to discuss recommendations regarding first-line treatment of patients with HER2-positive metastatic breast cancer.
Immunotherapy Combo Extends Survival for Patients with Aggressive Small Cell Lung Cancer, Based on Trial Results Presented by Dana-Farber at ESMO Congress 2026 News

Immunotherapy Combo Extends Survival for Patients with Aggressive Small Cell Lung Cancer, Based on Trial Results Presented by Dana-Farber at ESMO Congress 2026

Results suggest that introducing tarlatamab, a bispecific T-cell engager, earlier in treatment could meaningfully extend survival for a broader group of patients
Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Substudy Supports Reduced Risk of Metastasis and Death News

Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Substudy Supports Reduced Risk of Metastasis and Death

New analysis provides additional evidence on how the PROTEUS regimen compares with standard of care.
Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium News

Dana-Farber presents phase 3 lung cancer data in ESMO presidential symposium

Additional key study updates in prostate, breast and kidney cancer, and a special symposium focused on personalized cancer vaccines

Showing 1 - 12 of 802 results

Previous| 1 | 2 | 3 ...67 |Next